Primobolan 100mg/ml – Swiss Remedies

172.00$

Availability: In Stock

Primobolan is a moderate injectable anabolic steroid with a delayed effect. It is moderately anabolic and little androgenic. The effects of Primobolan are mostly similar to those of Primobolan tablets: moderate anabolic effect, moderate muscle gain, but quality.

  • Form: Injectable,
  • Ingredients: Methenolone Enanthate,
  • Concentration: 100mg / ml,
  • Presentation: 10 Ampoules of 1ml,
  • Recommended dosage: 75-150mg / day.

Buy  Primobolan 100mg/ml

Primabolan or Methenolone Enanthate is a long-acting anabolic, with extremely low androgenic properties.

Primabolan is characterized by a long ester, which means a slow absorption that allows to have a stable concentration of Methenolone in the blood. Like many other steroids, Methenolone Enanthate is widely used in medicine to treat tumors and dry breast disease, AIDS, etc.

Methenolone Enanthate is considered by bodybuilders as the mildest and most anabolic of all steroids, because of its side effects that occur rarely or almost never. Once in the blood, Primabolan does not turn into estrogen, which means: no negative effects like gynecomastia and / or water retention.

During a cure of Methenolone Enanthate, the results do not appear right away, but at the end of the cure one obtains a muscular tissue of quality. All versions of methenolone are good choices for dry cycles, both for men and for women, especially for athletes / bodybuilders whose goals are to maintain their muscle mass.

Side effects

Methenolone Enanthate is a derivative of DHT, so it binds very well with androgen receptors making it an effective fat burner. Methenolone Enanthate is very suitable for women because virilization symptoms such as hirsutism and deepening of the voice are very rare.

Dosage

The average effective dose is about 200 mg per week. Some men take up to 400 mg a week. With a dose of 200 mg per week over a period of 2 months, a beginner can expect a gain of 5 to 8 kg of dry muscle mass and sustainably acquired.

×